US EditionPublished • loading... • Updated
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $110.00
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $110.00
Gilead Sciences (NASDAQ:GILD – Free Report) had its price objective hoisted by The Goldman Sachs Group from $108.00 to $110.00 in a report issued on Friday,MarketScreener reports. They currently have a neutral rating on the biopharmaceutical company’s stock. A number of other research analysts also recently weighed in on GILD. Daiwa America upgraded Gilead Sciences […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
